The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer

eLife

Volumn 2015, Issue 4, 2015, Pages

  Wang, Eric ^a   Kawaoka, Shinpei ^a   Roe, Jae Seok ^a   Shi, Junwei ^a,b   Hohmann, Anja F ^a   Xu, Yali ^a,b   Bhagwat, Anand S ^a,b   Suzuki, Yutaka ^c   Kinney, Justin B ^a,b  

^a Simons Center for Quantitative Biology   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SHORT HAIRPIN RNA; TRANSCRIPTION COFACTOR TRIM 33; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENOTYPING TECHNIQUE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

MAMMALIA; MURINAE;

EID: 84929191424     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.06377.001     Document Type: Article

References (47)

1. Agricola E, Randall RA, Gaarenstroom T, Dupont S, Hill CS. 2011. Recruitment of TIF1gamma to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Molecular Cell 43: 85-96. doi: 10.1016/j.molcel.2011.05.020.
2. Alt FW, Yancopoulos GD, Blackwell TK, Wood C, Thomas E, Boss M, Coffman R, Rosenberg N, Tonegawa S, Baltimore D. 1984. Ordered rearrangement of immunoglobulin heavy chain variable region segments. The EMBO Journal 3:1209-1219.
3. Aucagne R, Droin N, Paggetti J, Lagrange B, Largeot A, Hammann A, Bataille A, Martin L, Yan KP, Fenaux P, Losson R, Solary E, Bastie JN, Delva L. 2011. Transcription intermediary factor 1gamma is a tumor suppressor in mouse and human chronic myelomonocytic leukemia. The Journal of Clinical Investigation 121:2361-2370. doi: 10.1172/JCI45213.
4. Bai X, Kim J, Yang Z, Jurynec MJ, Akie TE, Lee J, LeBlanc J, Sessa A, Jiang H, DiBiase A, Zhou Y, Grunwald DJ, Lin S, Cantor AB, Orkin SH, Zon LI. 2010. TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell 142:133-143. doi: 10.1016/j.cell.2010.05.028.
5. Bai X, Trowbridge JJ, Riley E, Lee JA, DiBiase A, Kaartinen VM, Orkin SH, Zon LI. 2013. TiF1-gamma plays an essential role in murine hematopoiesis and regulates transcriptional elongation of erythroid genes. Developmental Biology 373:422-430. doi: 10.1016/j.ydbio.2012.10.008.
6. Beard C, Hochedlinger K, Plath K, Wutz A, Jaenisch R. 2006. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 44:23-28. doi: 10.1002/gene.20180.
7. Bolden JE, Tasdemir N, Dow LE, van Es JH, Wilkinson JE, Zhao Z, Clevers H, Lowe SW. 2014. Inducible in vivo silencing of Brd4 identifies potential toxicities of sustained BET protein inhibition. Cell Reports 8:1919-1929. doi: 10.1016/j.celrep.2014.08.025.
8. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-1738. doi: 10.1126/science.286.5445.1735.
9. Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, MacQuarrie KL, Davison J, Morgan MT, Ruzzo WL, Gentleman RC, Tapscott SJ. 2010. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Developmental Cell 18:662-674. doi: 10.1016/j.devcel.2010.02.014.
10. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C. 2002. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. The New England Journal of Medicine 346:235-242. doi: 10.1056/NEJMoa011795.
11. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-823. doi: 10.1126/science.1231143.
12. Dow LE, Premsrirut PK, Zuber J, Fellmann C, McJunkin K, Miething C, Park Y, Dickins RA, Hannon GJ, Lowe SW. 2012. A pipeline for the generation of shRNA transgenic mice. Nature Protocols 7:374-393. doi: 10.1038/nprot.2011.446.
13. Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, Martello G, Stinchfield MJ, Soligo S, Morsut L, Inui M, Moro S, Modena N, Argenton F, Newfeld SJ, Piccolo S. 2009. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136:123-135. doi: 10.1016/j.cell.2008.10.051.
14. Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, Rugge M, Piccolo S. 2005. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121:87-99. doi: 10.1016/j.cell.2005.01.033.
15. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T. 2004. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. The New England Journal of Medicine 350:2572-2581. doi: 10.1056/NEJMoa032534.
16. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. 2003. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. The Journal of Experimental Medicine 198:1119-1126. doi: 10.1084/jem.20030411.
17. Fellmann C, Hoffmann T, Sridhar V, Hopfgartner B, Muhar M, Roth M, Lai DY, Barbosa IA, Kwon JS, Guan Y, Sinha N, Zuber J. 2013. An optimized microRNA backbone for effective single-copy RNAi. Cell Reports 5:1704-1713. doi: 10.1016/j.celrep.2013.11.020.
18. Grant CE, Bailey TL, Noble WS. 2011. FIMO: scanning for occurrences of a given motif. Bioinformatics 27: 1017-1018. doi: 10.1093/bioinformatics/btr064.
19. Hatakeyama S. 2011. TRIM proteins and cancer. Nature Reviews Cancer 11:792-804. doi: 10.1038/nrc3139.
20. He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massague J. 2006. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125:929-941. doi: 10.1016/j.cell.2006.03.045.
21. Herquel B, Ouararhni K, Davidson I. 2011. The TIF1alpha-related TRIM cofactors couple chromatin modifications to transcriptional regulation, signaling and tumor suppression. Transcription 2:231-236. doi: 10.4161/trns.2.5.17725.
22. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA. 2013. Super-enhancers in the control of cell identity and disease. Cell 155:934-947. doi: 10.1016/j.cell.2013.09.053.
23. Kusy S, Gault N, Ferri F, Lewandowski D, Barroca V, Jaracz-Ros A, Losson R, Romeo PH. 2011. Adult hematopoiesis is regulated by TIF1gamma, a repressor of TAL1 and PU.1 transcriptional activity. Cell Stem Cell 8:412-425. doi: 10.1016/j.stem.2011.02.005.
24. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339:823-826. doi: 10.1126/science.1232033.
25. Martlnez-Antonio A, Collado-Vides J. 2003. Identifying global regulators in transcriptional regulatory networks in bacteria. Current Opinion in Microbiology 6:482-489. doi: 10.1016/j.mib.2003.09.002.
26. Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, Buchman S, Chen CY, Chou A, Ienasescu H, Lim J, Shyr C, Tan G, Zhou M, Lenhard B, Sandelin A, Wasserman WW. 2014. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Research 42: D142-D147. doi: 10.1093/nar/gkt997.
27. Morita S, Kojima T, Kitamura T. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Therapy 7:1063-1066. doi: 10.1038/sj.gt.3301206.
28. Premsrirut PK, Dow LE, Kim SY, Camiolo M, Malone CD, Miething C, Scuoppo C, Zuber J, Dickins RA, Kogan SC, Shroyer KR, Sordella R, Hannon GJ, Lowe SW. 2011. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 145:145-158. doi: 10.1016/j.cell.2011.03.012.
29. Prinjha RK, Witherington J, Lee K. 2012. Place your BETs: the therapeutic potential of bromodomains. Trends in Pharmacological Sciences 33:146-153. doi: 10.1016/j.tips.2011.12.002.
30. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470:279-283. doi: 10.1038/nature09692.
31. Ram O, Goren A, Amit I, Shoresh N, Yosef N, Ernst J, Kellis M, Gymrek M, Issner R, Coyne M, Durham T, Zhang X, Donaghey J, Epstein CB, Regev A, Bernstein BE. 2011. Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells. Cell 147:1628-1639. doi: 10.1016/j.cell.2011.09.057.
32. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. 2013. Genome engineering using the CRISPR-Cas9 system. Nature Protocols 8:2281-2308. doi: 10.1038/nprot.2013.143.
33. Revilla-I-Domingo R, Bilic I, Vilagos B, Tagoh H, Ebert A, Tamir IM, Smeenk L, Trupke J, Sommer A, Jaritz M, Busslinger M. 2012. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. The EMBO Journal 31:3130-3146. doi: 10.1038/emboj.2012.155.
34. Scott EW, Simon MC, Anastasi J, Singh H. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-1577. doi: 10.1126/science.8079170.
35. Shi J, Vakoc CR. 2014. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Molecular Cell 54:728-736. doi: 10.1016/j.molcel.2014.05.016.
36. Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe JS, Minder JL, Mercan F, Wang E, Eckersley- Maslin MA, Campbell AE, Kawaoka S, Shareef S, Zhu Z, Kendall J, Muhar M, Haslinger C, Yu M, Roeder RG, Wigler MH, Blobel GA, Zuber J, Spector DL, Young RA, Vakoc CR. 2013. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes & Development 27:2648-2662. doi: 10.1101/gad. 232710.113.
37. Spitz F, Furlong EE. 2012. Transcription factors: from enhancer binding to developmental control. Nature Reviews Genetics 13:613-626. doi: 10.1038/nrg3207.
38. Steger DJ, Lefterova MI, Ying L, Stonestrom AJ, Schupp M, Zhuo D, Vakoc AL, Kim JE, Chen J, Lazar MA, Blobel GA, Vakoc CR. 2008. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Molecular and Cellular Biology 28:2825-2839. doi: 10.1128/MCB.02076-07.
39. Tsai WW, Wang Z, Yiu TT, Akdemir KC, Xia W, Winter S, Tsai CY, Shi X, Schwarzer D, Plunkett W, Aronow B, Gozani O, Fischle W, Hung MC, Patel DJ, Barton MC. 2010. TRIM24 links a non-canonical histone signature to breast cancer. Nature 468:927-932. doi: 10.1038/nature09542.
40. Venturini L, You J, Stadler M, Galien R, Lallemand V, Koken MH, Mattei MG, Ganser A, Chambon P, Losson R, de Thé H. 1999. TIF1gamma, a novel member of the transcriptional intermediary factor 1 family. Oncogene 18: 1209-1217. doi: 10.1038/sj.onc.1202655.
41. Whyte WA, Bilodeau S, Orlando DA, Hoke HA, Frampton GM, Foster CT, Cowley SM, Young RA. 2012. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 482:221-225. doi: 10.1038/ nature10805.
42. Williams RT, Roussel MF, Sherr CJ. 2006. Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of USA 103:6688-6693. doi: 10.1073/pnas.0602030103.
43. Willis SN, Adams JM. 2005. Life in the balance: how BH3-only proteins induce apoptosis. Current Opinion in Cell Biology 17:617-625. doi: 10.1016/j.ceb.2005.10.001.
44. Wunderlich Z, Mirny LA. 2009. Different gene regulation strategies revealed by analysis of binding motifs. Trends in Genetics 25:434-440. doi: 10.1016/j.tig.2009.08.003.
45. Xi Q, Wang Z, Zaromytidou AI, Zhang XH, Chow-Tsang LF, Liu JX, Kim H, Barlas A, Manova-Todorova K, Kaartinen V, Studer L, Mark W, Patel DJ, Massague J. 2011. A poised chromatin platform for TGF-beta access to master regulators. Cell 147:1511-1524. doi: 10.1016/j.cell.2011.11.032.
46. Zuber J, McJunkin K, Fellmann C, Dow LE, Taylor MJ, Hannon GJ, Lowe SW. 2011a. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nature Biotechnology 29:79-83. doi: 10.1038/nbt.1720.
47. Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, Taylor MJ, Johns C, Chicas A, Mulloy JC, Kogan SC, Brown P, Valent P, Bradner JE, Lowe SW, Vakoc CR. 2011b. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478:524-528. doi: 10.1038/nature10334.